UK consumer health company Haleon has announced a five-year collaboration with Microsoft to scale digital, data and AI capabilities across its business, accelerating delivery of its global strategy through expanded use of Microsoft Azure, Microsoft 365 Copilot and agentic AI tools across functions spanning consumer insights, supply chain, marketing, research and development, and commercial execution.

The agreement, reported by Morningstar, builds on Haleon's existing Microsoft relationship and extends into co-creation of high-impact AI use cases designed to drive measurable productivity and innovation outcomes.

Claire Dickson, Chief Digital and Technology Officer at Haleon, said: "By combining Microsoft's cloud and AI capabilities with Haleon's deep consumer health expertise, we're accelerating our AI progress, simplifying how we work, unlocking more value from our data, accelerating innovation and helping our teams make faster, smarter decisions to benefit our consumers."

The collaboration will enable Haleon to develop deeper consumer insights, drive product innovation at pace and streamline operations from supply chain through to commercial execution. Specific applications include faster scientific research and clinical content development, enhanced marketing personalisation and improved forecasting and decision-making across the business.

Darren Hardman, CEO of Microsoft UK and Ireland, said: "Haleon is moving with real pace and purpose on its AI journey, using Microsoft cloud and AI capabilities to turn ambition into impact across the entire organisation."

Microsoft Azure will serve as Haleon's core cloud platform, with enterprise-grade security capabilities including strengthened identity, governance and threat protection applied across AI-powered workflows. The agreement also advances next-generation agentic AI capabilities, enabling Haleon's digital and technology teams to manage, govern and secure intelligent digital agents working alongside staff across the organisation.

The partnership supports Haleon's stated ambition to build an AI-powered, decision-intelligent enterprise where data and insights flow seamlessly to enable faster, more consumer-centric decisions. The company has set a target of reaching one billion more consumers by 2030, with AI-driven operational efficiency and product personalisation central to achieving that goal.

Haleon's brands include Sensodyne, Panadol and Centrum, with the company operating across more than 100 markets globally.